Page 4 - Pages
P. 4

Prophylaxis                                                                                                            Pharmacotherapy


         Thromboprophylaxis for total knee replacement                                                                           Opioid-prescribing practices after common

         or total hip replacement surgery                                                                                        orthopaedic procedures





       Dr. Milind Patil                                                   10      12        10                                Dr Vivek Mittal                                            Target areas for future initiatives
                                                                          12
                                                                      Incidence of DVT                                                                                                   A  quality improvement questionnaire  study  was
       Joint Replacement Surgeon                                           8 6                                                Orthopedic Surgeon

       Revival Bone and Joint Hospital, Thane                              4 2                         2                      BLK Super Speciality Hospital, New Delhi                   conducted among orthopedic surgeons to assess the
                                                                           0
                                                                                                                                                                                         potential opioid safety initiatives.
                                                                               No prophylaxis  LMWH  Rivaroxaban                                                                         prescribing  practices  and  gain  perspective  on
                                                                                                                                                                                                                        [1]
       Introduction                                                                                                           Introduction
                                                                      Fig: Incidence of DVT per 1000 patients after no prophylaxis and
                                                                         thromboprophylaxis with LMWH and Rivaroxaban  [3]                                                               The opioid prescribing practices can be improved by
                                                                                                                              Acute and  chronic  pain carries  grave  economic,         developing training programs, increasing awareness,
       Venous  thromboembolism  (VTE)  is  a  serious             Total mortality also reduced from 5 to 2 per 1,000 with     operational, and personal consequences.  [1]
       complication of orthopedic surgery.   [1]                  rivaroxaban as compared to LMWH.  [3]                                                                                  use of opioid tracking databases, and formulation of a
                                                                                                                                                                                         standardized  recommended dose for common
                                                                                                                              Despite the guidelines promoting conservative pain                             [1]
       Low molecular weight heparin (LMWH) has been the           Conclusion                                                  management,  narcotic  prescriptions  have increased       orthopedic surgeries.
       standard of care for thromboprophylaxis after total                                                                    by 51% and fatal opioid overdoses tripled over the last
       knee  replacement  (TKR)  or  total  hip  replacement                                                                  6 years.  [1]                                              Clinical implication
       (THR) surgery.   [1]                                       For  patients  undergoing  THA/TKA,  the  evidence  is
                                                                  strong   and    sufficient   to   conclude   that
                                                                  thromboprophylaxis  with  rivaroxaban  is  associated       But, opioids  are the  mainstay  of pain management        The knowledge of opioid prescription variability and
       However, direct oral anticoagulants  (DOACs)  are                                                                      following orthopedic surgery.  [1]                         the prevailing opioid epidemic needs to be addressed
       increasingly being used as alternatives.   [1]             with  better  efficacy  outcomes  when  compared  with                                                                  and resolved in the Indian scenario.
                                                                  LMWH,  without  significant  differences  in  major
                                                                  bleeding and overall mortality.                             Therefore, to balance the benefits with the involved
       International guidelines for                                                                                           risks the opioids should be judiciously prescribed.  [1]   This  review  can  serve  as  an  exemplar  for  the
       thromboprophylaxis                                         References                                                                                                             reevaluation  of recommendations  and institutional
                                                                                                                                                                                         practices  to  reduce  excess  postoperative  opioid
       The most recent National Institute for health & Care       1.Haykal  T,  Adam  S,  Bala  A,  et  al.  Thromboprophylaxis  for   Variability in Opioid-prescribing Practic-        prescriptions.
       Excellence  (NICE  2018)  guidelines  recommend            orthopedic  surgery;  An  updated  meta-analysis.  Thromb  Res.   es  [2]
       anticoagulation  with  rivaroxaban  or  LMWH  after        2021;199:43-53.
       total hip or knee arthroplasty.   [2]                      2.D.R.  Anderson,  G.P.  Morgano,  C.  Bennett,  F.  Dentali,  C.W.   Level  III  observational  cohort  study  evaluated  the   References
                                                                  Francis, D.A. Garcia, et al., American Society of Hematology 2019   trends  and  variability  in  opioid  prescriptions  after
       Both  ACCP  (2012)  and  American  Society  of             guidelines  for  management  of  venous  thromboembolism:                                                              1.Kopp,  J.  A.,  Anderson,  A.  B.  et  al.  (2019).  Orthopedic  Surgeon
       Hematology  (ASH  2019)  recommends  extended              prevention of venous thromboembolism in surgical hospitalized   common orthopedic procedures.                          Decision-Making Processes for Postsurgical Opioid Prescribing.
       prophylaxis  of  35  days  and  19-42  days  respectively   patients, Blood Adv 3 (23) (2019) 3898–3944.                                                                          Military Medicine. Military Medicine, Vol. 185, March/April 2020
       over short-term prophylaxis.   [2, 3]                                                                                             A retrospective study from 2015 and 2016
                                                                  3.Y. Falck-Ytter, C.W. Francis, N.A. Johanson, C. Curley, O.E. Dahl,
                                                                                                                                                                                         2.Traven, Sophia A. MD; Brinton, Daniel L. PhD; Woolf, Shane K.
                                                                  S.  Schulman,  et  al.,  Prevention  of  VTE  in  orthopedic  surgery   Data on 73,921 subjects who underwent common
       Extended thromboprophylaxis with                                                                                                        orthopaedic procedures                    MD; Leddy, Lee R. MD; Gottschalk, Michael B. MD; Slone, Harris S.
                                                                  patients: antithrombotic therapy and prevention of thrombosis,
       Rivaroxaban                                                9th  ed:  American  College  of  Chest  Physicians  Evidence-  Based   From Truven Health Market Scan database         MD  Notable  Variability  in  Opioid-prescribing  Practices  After
                                                                                                                                                                                         Common  Orthopaedic  Procedures,  Journal  of  the  American
                                                                  Clinical  Practice  Guidelines,  Chest  141  (2  Suppl)  (2012)
       The  RECORD  clinical  trial  program  has  earlier        e278S–e325S.                                                                                                           Academy of Orthopaedic Surgeons: March 1, 2021 - Volume 29 -
       established  the  better  efficacy  of  rivaroxaban  over                                                                        Initial opioid   90-day prescription              Issue 5 - p 219-226.
                                                                                                                                                          (initial + refills)
                                                                                                                                       prescription
       LMWH in VTE prevention post TKA/THA  [4]                   4.Russell RD, Hotchkiss WR, Knight JR, Huo MH. The efficacy and
                                                                  safety of rivaroxaban for venous thromboembolism prophylaxis
                                                                  after  total  hip  and  total  knee  arthroplasty.  Thrombosis.
       In  addition,  the  extended  use  of  rivaroxaban  was
       studied in a prospective trial enrolling 2,400 patients    2013;2013:762310. doi:10.1155/2013/762310                               Median oral morphine equivalent and
                                                                                                                                           Interquartile range were analyzed
       after THA.   [3]
       Eight fewer symptomatic DVT per 1,000 was achieved                                                                           Patients undergoing soft-tissue only precedures required
       with  rivaroxaban  over  LMWH  after  34-day                                                                                     the fewest refills while patients undergoing
       prophylaxis.   [3]                                                                                                                total joint arthroplasty required the most.

                                                                                                                                                    [Ref: 2]
   1   2   3   4   5   6   7   8